1. Home
  2. PEW vs CRBU Comparison

PEW vs CRBU Comparison

Compare PEW & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GrabAGun Digital Holdings Inc.

PEW

GrabAGun Digital Holdings Inc.

N/A

Current Price

$1.61

Market Cap

56.7M

ML Signal

N/A

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

N/A

Current Price

$0.37

Market Cap

48.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PEW
CRBU
Founded
2007
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.7M
48.5M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
PEW
CRBU
Price
$1.61
$0.37
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
★ $5.00
AVG Volume (30 Days)
405.6K
★ 2.3M
Earning Date
11-12-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 3.64
EPS
★ N/A
N/A
Revenue
★ $96,449,000.00
N/A
Revenue This Year
$6.38
$170.62
Revenue Next Year
$6.53
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 3.57
N/A
52 Week Low
$1.76
$0.36
52 Week High
$3.97
$2.49

Technical Indicators

Market Signals
Indicator
PEW
CRBU
Relative Strength Index (RSI) 25.68 24.52
Support Level N/A N/A
Resistance Level $2.20 $0.58
Average True Range (ATR) 0.12 0.04
MACD -0.03 0.02
Stochastic Oscillator 0.70 1.08

Price Performance

Historical Comparison
PEW
CRBU

About PEW GrabAGun Digital Holdings Inc.

GrabAGun Digital Holdings Inc is a multi-brand eCommerce retailer of firearms, ammunition and related accessories. The Company's firearm products are ordered and paid for by customers online through the Company's eCommerce site and mobile app and are delivered to them on-premises through their choice of federal firearm licensed dealers nationwide. The Company's network of localized firearm dealers perform background checks on firearms purchasers and complete sales forms as mandated by federal and state firearm regulations.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Share on Social Networks: